
Cloud-native enterprise Quality Management System (EQMS) with 40+ configurable applications for quality, EHS, and compliance management, purpose-built for regulated industries including pharmaceuticals and medical devices.
Octave Reliance is an enterprise-grade Quality Management System (EQMS) that has been serving quality professionals for over 30 years. Acquired by Hexagon in April 2022 for $1.2B, Octave Reliance separated from Hexagon as an independent public company in May 2026 and is a cloud-native platform delivering 40+ integrated applications adaptable to unique business environments without requiring custom programming.
The platform provides data-enabled, integrated business process management capabilities. Octave Reliance serves diverse sectors including Life Sciences Pharmaceutical, Medical Device, Aerospace & Defense, Automotive, Food & Beverage, and Manufacturing.
For pharmaceutical and medical device companies, Octave offers dedicated Life Sciences Compliance applications including Lab Investigations, Quality Events management, Complaints Handling with eMDR (Electronic Medical Device Reporting), and 21 CFR Part 11 / EU Annex 11 compliant workflows. The platform captures electronic signatures at each process step with comprehensive audit trails and validation support as a closed system.
Workflows, forms, sections, fields, and reports are configurable without programming: "Reliance stood out because the software is based on quality management best practices—yet workflows, forms, sections, fields, reports and even the look-and-feel of the systems can be configured without programming." (Senior Manager of Global Quality Capabilities, Avanos Medical)
The platform integrates with enterprise systems including SAP, Oracle, and Octave's electronic submission gateway for medical device reporting. SaaS bookings grew at 60% CAGR from 2019–2022, accounting for half of bookings by 2022.
Best suited for mid-market to large enterprise organizations (100-2000+ employees) in regulated industries requiring comprehensive quality, compliance, and audit management capabilities. Serves 600+ customers globally including BD, Dexcom, Fresenius Kabi, Philips Healthcare, Terumo, and Zimmer Biomet.
Life Sciences Compliance applications include Complaints Handling with eMDR, Lab Investigations, 21 CFR Part 11 & Annex 11 compliance, and validation support
Cloud-native SaaS platform with multi-tenant architecture. Hosted infrastructure not specified but likely AWS or Azure given Octave's enterprise standards. Web-based interface accessible via modern browsers. Mobile app availability not explicitly stated.
RESTful API available for integrations with enterprise systems including SAP, Oracle, and third-party applications. Electronic submission gateway for medical device reporting (eMDR) integrates with FDA and regulatory bodies.
LDAP/Active Directory authentication supported with configurable password policies and expiration. Single Sign-On (SSO) capabilities likely available given enterprise focus. Role-based access control (RBAC) with granular permissions.
Platform emphasizes configurability without custom programming - workflows, forms, fields, sections, and reports can be configured to match business requirements. 40+ pre-built applications adaptable to unique environments.
Deployment model: Pure SaaS with regular platform updates. Validation-friendly upgrade processes designed to minimize re-validation efforts for regulated customers.
Subscription-based pricing model with per-user licensing:
Small businesses: $35-50 per user per month Mid-sized companies (up to 100 users): ~$30,000 annually Large enterprises (1000 users): ~$200,000 annually Global enterprise: Custom pricing based on scale
Pricing includes: Yearly subscriptions, platform support, add-on modules (QDL, Insights), and remote consulting (RC) hours. Additional implementation costs vary by organization size (see Implementation section).
Pricing personalized through the vendor's Octave Reliance product page (https://www.octave.com/products/asset-performance-management/reliance)
Revenue and growth metrics: - Octave Reliance generated ~$75M revenue in 2022 with 35% adjusted operating margin - SaaS bookings grew 60% CAGR from 2019-2022, accounting for 50% of bookings by 2022 - Acquired by Hexagon AB for $1.2B in April 2022 - 600+ customers globally across pharmaceuticals, medical devices, manufacturing, food & beverage, and other regulated industries
Best suited for: Mid-market to large enterprise organizations (100-2000+ employees) requiring comprehensive quality management with strong regulatory compliance capabilities. Particularly strong fit for life sciences, medical devices, and pharmaceutical companies needing 21 CFR Part 11 and EU Annex 11 compliance.
Implementation timeline varies by organization size and complexity: - Small businesses: 2-4 months with $5K-$10K implementation costs - Mid-sized companies (100 users): 4-6 months with $20K-$50K implementation costs - Large enterprises (1000+ users): 6-12 months with $100K-$200K implementation costs
Octave offers two validation approaches for regulated industries: 1. Self-validation: Octave provides Validation Execution Package documenting platform development, testing, and methodology 2. Professional validation consulting: Expert validation consultants ensure compliance with current regulatory requirements
Key implementation considerations: - Highly configurable without programming reduces customization time - Pre-built quality management best practices embedded in workflows - Integration with existing enterprise systems (SAP, Oracle) requires planning - LDAP/Active Directory integration for authentication - Data migration from legacy systems - User training and change management
Avanos Medical case study notes: Platform configurability enabled replacement of paper-based audit processes and MDSAP compliance across global geographies without extensive custom development.
Octave provides implementation support, training, and ongoing customer success resources. Prior to Octave's May 2026 separation from Hexagon, implementation support drew on Hexagon's broader manufacturing intelligence ecosystem.
Anonymous feedback from pharmaceutical professionals using this solution
4.3 out of 5
Based on 620 verified reviews
Users highlight configurability: workflows, forms, fields, sections, and reports can be customised without programming, letting organisations adapt the platform to their own business requirements. The platform is built on quality management best practices, providing a solid foundation while maintaining flexibility. Customers highlight responsive and helpful customer support that facilitates smooth integration and user adoption. The platform scales well across global operations, supporting MDSAP compliance across multiple geographies. Users value the comprehensive 40+ applications that cover quality, EHS, and compliance management in a unified system. G2 Winter 2025 awards recognised the platform for usability, results, and momentum.
Users report that despite overall configurability, certain areas have limited customization options that restrict workflow integration and complicate document review processes. Reporting capabilities are frequently criticized as limited and difficult to use, with some features becoming less accessible in newer versions - potential regression from older platform versions. The initial learning curve is steep, requiring significant training investment for new users. Support quality is inconsistent according to some reviewers, with varying levels of responsiveness and expertise. The pricing structure is complex with multiple components (subscriptions, MAUs/CCUs, add-ons, QDL/Insights, RC hours) that may overwhelm smaller organizations. Implementation costs for large enterprises can reach $100K-$200K, representing substantial upfront investment. The platform's enterprise focus and comprehensive feature set may be excessive for small organizations despite availability of small business pricing. Some users note that newer versions removed or reduced accessibility of certain features, indicating potential usability challenges with platform evolution.
Share your experience with Octave Reliance (formerly ETQ Reliance) anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section